When you join ISPE, you get unlimited, complimentary access to over 120 live and recorded webinars designed to keep you informed on the topics that matter most to you—whether that's advancing your Pharma 4.0? strategy, tackling GAMP? challenges, navigating ATMP developments, or staying current with GMP standards. Take $25 off your ISPE membership fee with code STPADDY25425 (valid through 17 March) or receive a $25 Amazon gift card with code ISPE25425 (valid through 28 March) when you join or renew. Join or renew: https://hubs.la/Q03bdf3m0
关于我们
ISPE, the International Society for Pharmaceutical Engineering, is the world’s largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland, USA and the Operations and Training Center in Tampa, Florida, USA.
- 网站
-
https://www.ISPE.org
ISPE的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- North Bethesda,Maryland
- 类型
- 非营利机构
- 创立
- 1980
- 领域
- Pharmaceutical Education and Training、Pharmaceutical Guidance Documents、Pharmaceutical Professional Community Building/Networking、Career Solutions、Drug Shortages、Pharmaceutical Quality Metrics和Blend Uniformity and Content Uniformity (BUCU) Initiative
地点
ISPE员工
动态
-
The future of the pharmaceutical industry is being shaped by rapid advancements in digital technologies, automation, and data analytics. As we look ahead to 2025, the concept of Pharma 4.0? is no longer just an aspirational vision—it is becoming a transformative reality that will redefine how medicines are developed, manufactured, and delivered to patients. Read more in this iSpeak blog by Christian W?lbeling:https://hubs.la/Q039Y_BX0
-
-
We are introducing each 2025 FOYA Submission Finalists, before the 2025 FOYA Category Winners are announced at the 2025 ISPE Europe Annual Conference in May. Erbe Elektromedizin GmbH's Erbe 4.i competence center prioritizes both sustainability and efficient collaboration. By consolidating all company functions—from product development and prototype manufacturing to commercial manufacturing and administration—it enables streamlined end-to-end exchange from R&D to customer training. This building project represents a milestone in sustainable industrial construction in Germany, combining ecological, economic, and social sustainability aspects. Learn more about Erbe Elektromedizin GmbH and the other 2025 FOYA Submission Finalists -https://hubs.la/Q039Z55W0 View upcoming FOYA Activities - https://hubs.la/Q039Z0Jp0
-
-
ISPE and the ISPE Foundation are proud to support a global community that empowers women in leadership across the pharmaceutical industry. With over 22,000 members worldwide, ISPE's Women in Pharma? program connects 3,800+ members across multiple regions, providing the training and leadership opportunities needed to drive change. Together, we’re amplifying voices and strengthening communities. Join us in celebrating International Women's Day and watch the video to learn more: https://hubs.la/Q039ZQG10 #WomenInPharma #InternationalWomensDay #IWD2025 #AccelerateAction
-
-
Don't miss the exclusive networking reception hosted by the ISPE Chesapeake Bay Area Chapter on 17 March during the 2025 ISPE Aseptic Conference. Connect with industry leaders, expand your network, and gain valuable insights at this must-attend event. Separate registration is required. Learn more and secure your spot: https://hubs.la/Q039YT4f0
-
-
We are introducing each 2025 FOYA Submission Finalists, before the 2025 FOYA Category Winners are announced at the 2025 ISPE Europe Annual Conference in May. Project Aurora is dedicated to advancing global healthcare through the establishment of the world's largest Plasma Base Fractionation Facility at CSL's Broadmeadows campus. Their key goals include increase plasma processing capacity, enhance operational efficiency, sustainability, support global healthcare needs, foster human connections, economic and community impact and allow for future expansion. These goals collectively aim to enhance CSL's capacity to deliver innovative and life-saving therapies while maintaining a strong commitment to sustainability and community impact. Learn more about CSL Behring and the other 2025 FOYA Submission Finalists -https://hubs.la/Q039tNh70 View upcoming FOYA Activities - https://hubs.la/Q039tpBB0
-
-
ISPE members don’t just stay informed—they stay ahead. With more than 35 ISPE Guidance Documents available in multiple languages, you can access the insights you need in a way that works best for you. Plus as an ISPE member, you get $300 off guides and complimentary access to over 20 ISPE Good Practice Guides. Use promo code ISPE25425 to receive a $25 Amazon gift card when you join or renew your ISPE membership. Visit https://hubs.ly/Q039jJt20
-
-
As we approach International Women’s Day 2025 on 8 March, this year’s theme highlights the importance of accelerating action. ISPE’s Women in Pharma? embodies these principles by creating a platform for connection, growth, and empowerment. Hear what these Women in Pharma? members have to say about the value of Women in Pharma on International Women’s Day. Read more in this iSpeak blog: https://hubs.la/Q039jkYw0
-
-
Solid organs for human transplant derived from Xenotransplantation and regenerative medicine, what is it and how are companies approaching different product modalities with the advancements in science and technology. Join Matthew VonEsch at the 2025 ISPE Aseptic Conference as he discusses how science and therapeutic production opportunities are advancing and take a look at how one group is interpreting guidance to design, construct, and operate a facility that only years ago had no examples to reference. Learn more and view agenda: https://hubs.la/Q039hW-40
-
-
We are seeking your assistance in identifying colleagues within the pharmaceutical industry who would be well-suited to serve on the ISPE International Board of Directors. To represent a global view of our industry and ensure organizational success, ISPE seeks a diverse International Board of Directors that appropriately reflects our overall membership. If you know of someone who you believe would be a good fit for the 2025-2026 ISPE International Board of Directors, we encourage you to reach out to them, confirm their willingness to be considered, and send a completed nomination form along with the nominee's curriculum vitae or resume to [email protected]. Submit your nomination: https://hubs.la/Q0390_q_0
-